Skip to content

Agrx股票zacks

Agrx股票zacks

Agile Therapeutics (AGRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates PRINCETON, N.J., May 11, 2020 -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer,. Zacks • last Stock screener for investors and traders, financial visualizations. Find the latest Micron Technology, Inc. (MU) stock quote, history, news and other vital information to help you with your stock trading and investing. View Agile Therapeutics Inc AGRX investment & stock information. Get the latest Agile Therapeutics Inc AGRX detailed stock quotes, stock data, Real-Time ECN,   AGRX: Agile Therapeutics Inc broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. Should I buy Agile Therapeutics, Inc. (AGRX)? Use the Zacks Rank and Style Scores to find out is AGRX is right for your portfolio.

Square, Inc. Class A Common Stock (SQ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Stock Picks, Stock Market Investing | Seeking Alpha Scotts Miracle-Gro raises full-year earnings, revenue guidance. Scotts Miracle-Gro (NYSE:SMG) +5.5% after-hours after raising its FY 2020 forecast for adjusted EPS to $5.65-5.85 from previous 股吧个股吧列表_东方财富网旗下股票社区_东方财富网股吧

FINVIZ.com - Stock Screener

检索结果_新浪财经_新浪网

Agile Therapeutics (AGRX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The online brokerage that makes you a smarter investor Our knowledgeable professionals and industry leading tools are united to do one thing: make you a smarter, more confident investor. Open new account Learn more. When the market swings, learn how to swing back. Get expert insights to help navigate the ups and downs of the market with 检索结果_新浪财经_新浪网 MITTS linked to S&P 500 Index 2014) MGK (领航 超大盘股票成长型 ETF) MGPI (MGP Ingredients Inc.) MGR (Affiliated Managers Group Inc.) MGT (MGT Capital Investments) MGV (Vanguard Mega Cap Value ETF) MGYR (Magyar Bancorp Inc.) MHC (2% Minimum Coupon On Spx) MHE (BlackRock Massachusetts Tax-Exempt Trust) MHF (Western Asset Municipal High View Agile Therapeutics Inc AGRX investment & stock information. Get the latest Agile Therapeutics Inc AGRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Apr 1, 2020 Agile Therapeutics (AGRX) closed at $1.86 in the latest trading session, marking no change from the prior day.

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style. We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating: 新浪财经免费提供股票、基金、债券、外汇等行情数据以及其他资料均来自相关合作方,仅作为用户获取信息之目的,并不构成投资建议。 新浪财经以及其合作机构不为本页面提供信息的错误、残缺、延迟或因依靠此信息所采取的任何行动负责。 MarketBeat's community ratings are surveys of what our community members think about Agile Therapeutics and other stocks. Vote “Outperform” if you believe AGRX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AGRX will underperform the S&P 500 over the long term. You may vote once every thirty days. Agile Therapeutics (AGRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Apex Business WordPress Theme | Designed by Crafthemes